Xiangjun Qian

Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.

Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 28, 2025

Hepatocyte-derived LRG1 primes the liver for metastasis and impairs immunotherapy.

Hepatocyte-derived LRG1 primes the liver for metastasis and impairs immunotherapy.

Journal: Cellular & molecular immunology
Published: September 02, 2025

Corrigendum to "CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma" [Cancer Lett. 614 (2025) 217473].

Corrigendum to "CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma" [Cancer Lett. 614 (2025) 217473].

Journal: Cancer letters
Published: May 11, 2025

Age-dependent prognostic significance of neutrophil-to-HDL ratio in hepatocellular carcinoma patients.

Age-dependent prognostic significance of neutrophil-to-HDL ratio in hepatocellular carcinoma patients.

Journal: Frontiers in oncology
Published: April 30, 2025

ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage-Mediated Metastatic Colonization.

ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage-Mediated Metastatic Colonization.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2025

Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer.

Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer.

Journal: Hepatology international
Published: January 21, 2025

PSMD1 inhibition suppresses tumor progression and enhances antitumor immunity by modulating the RTKN/β-catenin/PD-L1 axis in hepatocellular carcinoma.

PSMD1 inhibition suppresses tumor progression and enhances antitumor immunity by modulating the RTKN/β-catenin/PD-L1 axis in hepatocellular carcinoma.

Journal: Cell death & disease
Published: January 19, 2025

Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma.

Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma.

Journal: Cancer medicine
Published: January 14, 2025

CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma.

CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma.

Journal: Cancer letters
Published: September 24, 2024

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.

Journal: Cancer letters
Published: December 12, 2023

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis.

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis.

Journal: Journal of visualized experiments : JoVE
Published: March 20, 2023

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.

Journal: Frontiers in oncology
Published: March 03, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026